Vor Ort
Merkzettel Warenkorb
Produktbild: Crohn's Disease and Ulcerative Colitis
- 10%

Crohn's Disease and Ulcerative Colitis From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach

10% sparen

172,99 € UVP 192,59 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

10.03.2017

Abbildungen

XX, 695 p. 204 illus., 144 illus. in color.

Herausgeber

Daniel C. Baumgart

Verlag

Springer

Seitenzahl

695

Maße (L/B/H)

28,5/21,5/4,4 cm

Gewicht

1968 g

Auflage

Second Edition 2017

Sprache

Englisch

ISBN

978-3-319-33701-2

Beschreibung

Rezension

“This very complete book is an excellent resource on inflammatory bowel disease (IBD), discussing in detail all aspects of Crohn's disease and ulcerative colitis. … This book is written for a very broad audience, from physicians and scientists to all healthcare personnel, who deal with IBD patients. … All areas are covered in detail. Even though this is a large book, it is easy to read.” (Henrique Fernandez, Doody’s Book Reviews, September, 2017) 

Portrait

Daniel C. Baumgart, MD

Inflammatory Bowel Disease Center

Department of Gastroenterology and Hepatology

Charité  Medical Center--Virchow Hospital

Medical School of the Humboldt University of Berlin

Berlin, Germany

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

10.03.2017

Abbildungen

XX, 695 p. 204 illus., 144 illus. in color.

Herausgeber

Daniel C. Baumgart

Verlag

Springer

Seitenzahl

695

Maße (L/B/H)

28,5/21,5/4,4 cm

Gewicht

1968 g

Auflage

Second Edition 2017

Sprache

Englisch

ISBN

978-3-319-33701-2

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Crohn's Disease and Ulcerative Colitis

  • Foreword.- Preface.- Environmental Factors in the Epidemiology of Inflammatory Bowel Disease.- The Immune System in Health.- Understanding the Epithelial Barrier in IBD.- Intestinal Microbiology and Ecology in Crohn’s Disease and Ulcerative Colitis.- The Immune System in Inflammatory Bowel Disease: Antimicrobial Peptides.- Vascular Responses to Intestinal Inflammation.- Immunobiology of Human Dendritic Cells in Inflammatory Bowel Disease.- Immunobiology of T-cells in Inflammatory Bowel Disease.- Immunology of B-cells in Inflammatory Bowel Disease.- Immune Cells: Monocytes and Macrophages.- Immune Functions of Epithelial Cells in Inflammatory Bowel Disease.- Autophagy and Endoplasmic Reticulum Stress.- Matrix Metalloproteinases.- Paradigm of T-cell Differentiation in Irritable Bowel Disease.- Pharmacological Intervention Studies Using Mouse Models of Chronic Intestinal Inflammation.- Stem Cells and Organoids to Study Epithelial Cell Biology in Inflammatory Bowel Disease.- Enhanced Endoscopy.- Magnetic Resonance Enterography.- Computed Tomography Enterography and Inflammatory Bowel Disease.- Ultrasound in Inflammatory Bowel Disease.- Laboratory Evaluation, Including Novel Diagnostic Markers.- Pathology of Inflammatory Bowel Disease.- Objective Assessment of Clinical Disease Activity.- Objective Assessment of Endoscopic Disease Activity and Mucosal Healing.- Evaluation of Quality of Life in Crohn’s Disease and Ulcerative Colitis: What Is Health-Related Quality of Life?.- Evaluation of Health Economics in Inflammatory Bowel Disease.- The Natural History of Inflammatory Bowel Disease.- Conventional Medical Management of Crohn’s Disease: Sulfasalazine.- Steroid Therapy for Crohn’s Disease.- Thiopurines in Crohn’s Disease.- Conventional Medical Management of Crohn’s Disease: Methotrexate.- Adalimumab for the Treatment of Crohn’s Disease.- Biologic Therapy of Crohn’s Disease: Certolizumab.- Biologic Therapy of Crohn’s Disease: Infliximab.- Briakinumab and Ustekinumab: Anti-p40 Antibodies for Inflammatory Bowel Disease Treatment.- Biologic Therapy of Crohn’s Disease: Natalizumab, Vedolizumab and anti-MadCAM.- Optimal Management of Fistulizing Crohn’s Disease.- Sulfasalazine and 5-aminosalicylates for Ulcerative Colitis.- Conventional Therapy of Ulcerative Colitis: Corticosteroids.- Medical Management of Ulcerative Colitis: Conventional Therapy—Azathioprine.- Calcineurin Inhibitors in Ulcerative Colitis.- Biologic Therapy in Moderate-to-Severe Ulcerative Colitis: Infliximab.- Biologic Therapy of Ulcerative Colitis: Adalimumab.- Biologic Therapy of Ulcerative Colitis: Golimumab.- Biologic Therapy of Ulcerative Colitis: Natalizumab, Vedolizumab, Etrolizumab (rHUMab beta 7), antiMadCAM.- Probiotics, Prebiotics, and Antibiotics in Inflammatory Bowel Disease.- Biosimilars in the Treatment of Inflammatory Bowel Disease.- Step-up versus Top-down Approach in Crohn’s Disease.- Leukocytapheresis Therapy of Inflammatory Bowel Diease.- Surgical Management of Crohn’s Disease and Ulcerative Colitis.- Extraintestinal Manifestations: Autoimmune Hepatitis.- Primary Sclerosing Cholangitis.- Autoimmune Pancreatitis and Other Organ Involvement.- Cutaneous and Oral Manifestations of Inflammatory Bowel Disease.- Arthritis, Arthropathy and Osteoporosis in Inflammatory Bowel Disease.- Nutrition in Inflammatory Bowel Disease.- Pregnancy and Fertility in Inflammatory Bowel Disease.- Pediatric Aspects of Inflammatory Bowel Disease.- Management and Prevention of Infectious Diseases in Inflammatory Bowel Disease Patients.- Incidence of Cancer and Screening in Inflammatory Bowel Disease.- Inflammatory Bowel Diseases: How to Identify High Risk Patients.- Patient Perspective on Inflammatory Bowel Disease.- Patient Resources in Inflammatory Bowel Disease.